Exosomal circRNAs: key modulators in breast cancer progression DOI Creative Commons
Guozhen Liu, Quan Liu,

Lingmei Jia

и другие.

Cell Death Discovery, Год журнала: 2025, Номер 11(1)

Опубликована: Апрель 24, 2025

Abstract Breast cancer (BC) poses significant challenges globally, necessitating a deeper understanding of its complexities. Exosomes are cell-specific secreted extracellular vesicles interest, characterized by lipid bilayer structure. can carry variety bioactive components, including nucleic acids, lipids, amino and small molecules, to mediate intercellular signaling. CircRNAs novel class single-stranded RNA closed-loop mainly exert ceRNA functions intricately modulate gene expression signaling pathways in breast cancer, influencing tumor progression therapeutic responses. The unique packaging circRNAs within exosomes serves as genetic information transmitters, facilitating communication between BC cells microenvironmental cells, thereby regulating critical aspects progression, immune evasion, drug resistance. Besides, exosomal possess the capabilities serving diagnostic biomarkers BC, due their stability, specificity, regulatory roles tumorigenesis metastasis. Therefore, this review aims elucidate mechanisms well potential for diagnosis therapeutics. ongoing investigations will potentially revolutionize treatment paradigms improve patient outcomes BC.

Язык: Английский

GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation DOI Creative Commons
Yikai Shen, Jie Lin,

Tianlu Jiang

и другие.

Journal of Experimental & Clinical Cancer Research, Год журнала: 2025, Номер 44(1)

Опубликована: Янв. 25, 2025

Abstract Background Exosomes, as extracellular membrane vesicles, play important roles in intercellular communication and can influence tumour progression. Circular RNAs (circRNAs) have been reported various malignancies are also components of exosomes. However, the role exosomal circRNAs gastric cancer (GC) progression has not completely clarified. Methods The enriched GC were identified using circRNA sequencing. biological function circMAN1A2 was investigated a series vitro vivo experiments. PKH-67 staining used to label molecular mechanism via mass spectrometry, immunoprecipitation, Western blot, single-cell RNA-sequencing data analyses. Results In our study, we determined that (hsa_circ_0000118) GC-derived Higher expression related poor survival patients (HR = 2.917, p 0.0120). Exosomal promoted suppressed antitumour activity T cells. Moreover, bound SFPQ cells cells, promoting G1/S phase transition cell cycle while inhibiting activation receptor signalling pathway decrease activity. Mechanistically, competed with FBXW11 for binding SFPQ, preventing FBXW11-mediated k48-linked ubiquitination protein degradation, thereby stabilizing expression. Conclusions Our work confirms critical immunosuppression GC. This novel axis circMAN1A2-SFPQ provides new insights into circRNA-based diagnostic therapeutic strategies.

Язык: Английский

Процитировано

2

Exosomal circ‐0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7/NRF2 axis DOI Creative Commons
Minyu Zhuang, Xiaoqiang Zhang, Jie Ji

и другие.

Clinical and Translational Medicine, Год журнала: 2024, Номер 14(8)

Опубликована: Авг. 1, 2024

Abstract Background Breast cancer (BC) is one of the most prevalent malignant tumours that threatens women health worldwide. It has been reported circular RNAs (circRNAs) play an important role in regulating tumour progression and microenvironment (TME) remodelling. Methods Differentially expression characteristics immune correlations circRNAs BC were verified using high‐throughput sequencing bioinformatic analysis. Exosomes characterised by nanoparticle transmission electron microscopy tracking The biological function circ‐0100519 development was demonstrated both vitro vivo. Western blotting, RNA pull‐down, immunoprecipitation, flow cytometry, luciferase reporter conducted to investigate underlying mechanism. Results Circ‐0100519 significant abundant tissues related poor prognosis. can be encapsulated into secreted exosomes, thereby promoting cell invasion metastasis via inducing M2‐like macrophages polarisation.Mechanistically, acted as a scaffold enhance interaction between deubiquitinating enzyme ubiquitin‐specific protease 7 (USP7) nuclear factor‐like 2 (NRF2) macrophages, USP7‐mediated deubiquitination NRF2. Additionally, HIF‐1α could upstream effector transcription. Conclusions Our study revealed exosomal potential biomarker for diagnosis prognosis, inhibitor PX‐478 may provide therapeutic target BC.

Язык: Английский

Процитировано

5

Unravelling the role of ubiquitin-specific proteases in breast carcinoma: insights into tumour progression and immune microenvironment modulation DOI Creative Commons
Huiyuan Yang,

Tingting Sun,

Zhenni Sun

и другие.

World Journal of Surgical Oncology, Год журнала: 2025, Номер 23(1)

Опубликована: Фев. 20, 2025

Breast cancer is a prevalent malignancy worldwide, and its treatment has increasingly shifted towards precision medicine, with immunotherapy emerging as key therapeutic strategy. Deubiquitination, an essential epigenetic modification, regulated by deubiquitinating enzymes (DUBs) plays critical role in immune function tumor progression. Ubiquitin-specific proteases (USPs), prominent subgroup of DUBs, are involved regulating cell functions, antigen processing, T development the context breast cancer. Certain USPs also modulate differentiation cells, such myeloid-derived suppressor cells (MDSCs) regulatory (Tregs), within microenvironment. Furthermore, several influence expression PD-L1, thus affecting efficacy checkpoint inhibitors. The overexpression may promote evasion, contributing to resistance. This review elucidates modulating microenvironment responses Additionally, it discusses effective strategies for combining USP inhibitors other agents enhance outcomes. Therefore, targeting presents potential overcome drug resistance, offering more strategy patients.

Язык: Английский

Процитировано

0

Tumor-derived extracellular vesicles: key drivers of immunomodulation in breast cancer DOI Creative Commons
Jieming Li, Shuo Yu, Min Rao

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Март 4, 2025

Breast cancer (BC) remains a significant global health challenge characterized by its heterogeneity and treatment complexities. Extracellular vesicles (EVs) are small membranous particles released cells, facilitating intercellular communication transporting bioactive molecules such as proteins, lipids, nucleic acids. Tumor-derived EVs have emerged pivotal regulators in the tumor microenvironment (TME) drivers of BC progression. These carry diverse cargoes molecules, influencing critical processes immune modulation, angiogenesis, metastasis. By altering behaviors cells including macrophages, dendritic T tumor-derived contribute to evasion growth. Furthermore, play role mediating drug resistance, impacting effectiveness therapeutic interventions. Understanding multifaceted roles is essential for development innovative strategies. Targeting pathways mediated holds promise enhancing efficacy treatments improving patient outcomes. This comprehensive review provides insights into intricate interactions modulation progression, highlighting potential targets avenues novel therapies.

Язык: Английский

Процитировано

0

Exosomal circRNAs: key modulators in breast cancer progression DOI Creative Commons
Guozhen Liu, Quan Liu,

Lingmei Jia

и другие.

Cell Death Discovery, Год журнала: 2025, Номер 11(1)

Опубликована: Апрель 24, 2025

Abstract Breast cancer (BC) poses significant challenges globally, necessitating a deeper understanding of its complexities. Exosomes are cell-specific secreted extracellular vesicles interest, characterized by lipid bilayer structure. can carry variety bioactive components, including nucleic acids, lipids, amino and small molecules, to mediate intercellular signaling. CircRNAs novel class single-stranded RNA closed-loop mainly exert ceRNA functions intricately modulate gene expression signaling pathways in breast cancer, influencing tumor progression therapeutic responses. The unique packaging circRNAs within exosomes serves as genetic information transmitters, facilitating communication between BC cells microenvironmental cells, thereby regulating critical aspects progression, immune evasion, drug resistance. Besides, exosomal possess the capabilities serving diagnostic biomarkers BC, due their stability, specificity, regulatory roles tumorigenesis metastasis. Therefore, this review aims elucidate mechanisms well potential for diagnosis therapeutics. ongoing investigations will potentially revolutionize treatment paradigms improve patient outcomes BC.

Язык: Английский

Процитировано

0